美国临床详情页--招募信息

{ "code": 200, "msg": "查询成功", "data": [ { "status_name": "Not yet recruiting", "estimated_enrollment": "100", "original_estimated_enrollment": "100", "estimated_completion_date": "2023-09-01", "estimated_primary_date": "2023-09-01", "eligibility_criteria": [ "Inclusion Criteria:", "Adult patient (aged ≥18 years)", "Patients suffering from CIDP according to EFNS/PNS 2010 criteria", "Planned switch from IVIg to Hizentra®", "Patient treated with at least 3 courses of IV immunoglobulin and deemed by the investigator to be dependent on immunoglobulins", "Patient deemed to be stable, with no change in their treatment for the disease during the 3 months prior to inclusion", "Patients who have a smart phone, a tablet or a computer", "Patients who have been informed verbally and in writing of the purposes of the study", "Exclusion Criteria:", "Concomitant participation in an interventional clinical study" ], "sex_gender": "{\"eligible\": 3, \"gender_desc\": null, \"based_eligibility\": null}", "ages_info": "18 Years and older (Adult, Older Adult)", "accepts_healthy": 2, "contacts_info": [ { "email": "clinicaltrials@cslbehring.com", "contacts": "Trial Registration Coordinator", "telephone": "610-878-4000" } ], "listed_countries": [ "France" ], "removed_countries": null } ] }

美国临床详情页--招募信息

美国临床详情页--招募信息

请求参数

参数名

类型

描述

必填

响应参数

参数名

类型

描述

必填

说明 / 示例